Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
about
Radiation dose effect in locally advanced non-small cell lung cancermicroRNA-664 enhances proliferation, migration and invasion of lung cancer cellsCRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experienceFludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study.Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy in Chinese patients with nonsmall-cell lung cancer: A multicentre randomized controlled trial.Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.Vinorelbine for non-small cell lung cancer.An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma.Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.
P2860
Q26823043-B050AEFA-5256-45D9-AF50-7D95114A6671Q33745073-37D4E154-0A59-435E-9F2A-6731D4851F1FQ33808203-EFDB975F-9887-4997-94C0-51D46246EFFAQ35030387-2C59691F-F283-4BCA-B3D4-DA805E4EB6E3Q35167387-1D627AC8-5C8E-4BC8-9189-116E9AD7DA85Q36708112-EE4819AE-036F-457C-AD9D-DC07F6A226D9Q36946823-89BC03A3-9FA6-40F5-98EB-5D7FA4CE3F0BQ37256849-2ED259C3-C41E-4A81-BCCB-6CB5CFF64E80Q37513753-AFC6C326-5A9F-4120-AD8E-8193DFA2AE77Q37720767-500FF7E4-CA66-4746-AA68-7A4398C0A95AQ38109229-306B76B7-9BD0-4771-B2CD-E2564FEA6F0EQ41977987-3BF7988E-4988-4C01-8813-11C80795628BQ44957834-0D9D4001-0730-460D-94D4-AC8AF420F5B7Q45122603-16DEA68E-8FCE-494C-9D0B-C3B8DAF8C911Q47353436-86B0DE35-55DC-4BF0-B0F6-121FB661A0EA
P2860
Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Concurrent chemoradiotherapy w ...... II non-small cell lung cancer.
@en
type
label
Concurrent chemoradiotherapy w ...... II non-small cell lung cancer.
@en
prefLabel
Concurrent chemoradiotherapy w ...... II non-small cell lung cancer.
@en
P2093
P1476
Concurrent chemoradiotherapy w ...... II non-small cell lung cancer.
@en
P2093
Hironobu Ohmatsu
Kaoru Kubota
Keiji Nihei
Kiyotaka Yoh
Koichi Goto
Nagahiro Saijo
Seiji Niho
Tomonori Fujii
Yoichi Naito
Yutaka Nishiwaki
P304
P356
10.1097/JTO.0B013E3181753B38
P577
2008-06-01T00:00:00Z